Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abidol vs Abidol plus Interferon for COVID-19 Pneumonia
NCT04254874Phase 4Unknown
- Sponsor
- Tongji Hospital
- Start
- Feb 2020
- Primary completion
- Jun 2020
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2b in COVID-19 pneumonia, sponsored by Tongji Hospital. Status: unknown.
02
Drugs
peginterferon alfa-2b
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04254874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04254874.